celgosivir: Clinical Trials

7 completed, 1 unknown, 1 withdrawn. 8 Phase 2, 3 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	8	Completed 6, Unknown 1, Withdrawn 1
Phase 1	3	Completed 2, Withdrawn 1

Follow celgosivir: new trials by email Literature Review of celgosivir trials Research Report on celgosivir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore Celgosivir, Modipafant 50mg, Placebo - Dengue Fever	Phase 1 / Phase 2	Withdrawn	Singapore General Hospital		2018-12-01	2020-03-23
Celgosivir as a Treatment Against Dengue celgosivir, placebo - Dengue Fever	Phase 1 / Phase 2	Completed	Singapore General Hospital	50	2012-07-01	2013-12-02
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C Celgosivir, Peginterferon alfa 2b + ribavirin - Chronic Hepatitis C	Phase 2	Unknown	BioWest Therapeutics Inc	50	2006-06-01	2008-04-08
An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection Celgosivir - Hepatitis C, Chronic	Phase 2	Completed	BioWest Therapeutics Inc	60	2006-02-01	2008-01-21
A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection Celgosivir - Hepatitis C, Chronic	Phase 2	Completed	BioWest Therapeutics Inc	60	2005-09-01	2006-09-29
A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection Celgosivir - Hepatitis C, Chronic	Phase 2	Completed	BioWest Therapeutics Inc	43	2004-10-01	2005-09-12
A Study of MDL 28,574A in HIV-Infected Patients Celgosivir hydrochloride - HIV Infections	Phase 1	Completed	Hoechst Marion Roussel			2005-06-24
A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients Celgosivir hydrochloride - HIV Infections	Phase 2	Completed	Hoechst Marion Roussel	200		2005-06-24
A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients Celgosivir hydrochloride - HIV Infections	Phase 2	Completed	Hoechst Marion Roussel	200		2005-06-24

Conditions studied

Hepatitis C (4)  ·  Hepatitis C, Chronic (4)  ·  HIV Infections (3)  ·  AIDS-Related Complex (2)  ·  Dengue (2)  ·  Acquired Immunodeficiency Syndrome (1)

Sponsors

BioWest Therapeutics Inc (4)  ·  Hoechst Marion Roussel (3)  ·  Singapore General Hospital (2)

Countries

Canada (3)  ·  United States (3)  ·  Singapore (2)

Top investigators

Jim Pankovich (4)  ·  Jenny Low, Dr (1)  ·  Subhash Vasudevan, PhD (1)

Results publications

PMID 24877997, PMID 26794905, PMID 27509020